Key result
HRV14 enters ICAM-1-expressing cells via a macropinocytosis-like pathway independent of clathrin, caveolin, and flotillin.
The study identifies that major group human rhinovirus 14 enters cells via a unique pathway independent of clathrin, caveolin, and flotillin, sharing characteristics with macropinocytosis.
Does not alter clinical management of rhinovirus; leaves open in vivo relevance and therapeutic targeting.
Intercellular adhesion molecule 1 (ICAM-1) mediates binding and entry of major group human rhinoviruses (HRVs). Whereas the entry pathway of minor group HRVs has been studied in detail and is comparatively well understood, the pathway taken by major group HRVs is largely unknown. Use of immunofluorescence microscopy, colocalization with specific endocytic markers, dominant negative mutants, and pharmacological inhibitors allowed us to demonstrate that the major group virus HRV14 enters rhabdomyosarcoma cells transfected to express human ICAM-1 in a clathrin-, caveolin-, and flotillin-independent manner. Electron microscopy revealed that many virions accumulated in long tubular structures, easily distinguishable from clathrin-coated pits and caveolae. Virus entry was strongly sensitive to the Na(+)/H(+) ion exchange inhibitor amiloride and moderately sensitive to cytochalasin D. Thus, cellular uptake of HRV14 occurs via a pathway exhibiting some, but not all, characteristics of macropinocytosis and is similar to that recently described for adenovirus 3 entry via alpha(v) integrin/CD46 in HeLa cells.
No takes yet. Share an insight, caveat, or question.
Khan et al. (2010) studied Human Rhinovirus 14 infection. Human Rhinovirus 14 (HRV14) was evaluated on Viral entry pathway characteristics. Human rhinovirus 14 enters rhabdomyosarcoma cells expressing human ICAM-1 via a clathrin-, caveolin-, and flotillin-independent pathway exhibiting characteristics of macropinocytosis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: